TRexBio

South San Francisco, CA · Founded 2018 · Privately Held (backing)

Developer of immunoregulatory medicines designed to restore immune balance in inflammatory diseases through tissue regulatory T cell biology. TRexBio is based in South San Francisco, CA and was founded in 2018. It is valued at about $274 million as of Oct 2026, set by institutional fund marks. It has raised $222 million.

PMV mark · valuation

$274.0M

Oct 2026

Priced at

—

Total raised

$222.1M

Last round

—

How much has TRexBio raised?

$222.1Macross 0 recorded rounds

Free account

More of TRexBio with a free account

·The complete investor list: 14 names
·Watch TRexBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

TRexBio investors

14 investors are on record for TRexBio, including Alexandria Venture Investments, Johnson & Johnson JJDC, Polaris Partners and SV Health Investors. By type, the record holds 3 venture capital firms and 3 hedge funds.

For fundraisers

Raising for a company like TRexBio?

14 investors have backed TRexBio.

See all 14 investors →

Frequently asked about TRexBio

How much has TRexBio raised?: TRexBio has raised $222.1M in total across 0 recorded funding rounds.